Evaluating the efficacy of triamcinolone acetonide chewing gum in treating recurrent aphthous stomatitis: A randomized clinical study Triamcinolone Gum for Recurrent Mouth Ulcers
Iranian Journal of Pharmaceutical Sciences,
Vol. 21 No. 1 (2025),
21 January 2025
,
Page 61- 69
https://doi.org/10.22037/ijps.v21i1.46622
Abstract
Recurrent Aphthous Stomatitis (RAS) is a prevalent inflammatory disorder that affects the mouth and is defined by painful ulcers. The precise cause of the condition is still unknown, and the major approach to treatment is mainly centered around managing the symptoms. Triamcinolone acetonide (TA) is a commonly used medication for several conditions. However, due to its potential benefits, there is growing interest in exploring novel drug delivery systems, such as medicated chewing gum (MCG). This study introduces a novel MCG formulation containing TA (T-MCG). We investigated its in vitro drug release and content uniformity before conducting a clinical trial comparing the efficacy of T-MCG versus placebo in patients with RAS. The T-MCG formulation exhibited a sustained release of TA for 120 minutes. The clinical findings demonstrated a notable decrease in the ulcer's size and the mean wound healing period. The results suggest that T-MCG not only improves the effectiveness of TA treatment by releasing the drug over a longer period and allowing it to stay in the mouth longer but also increases patient adherence due to its pleasant composition.
- Triamcinolone acetonide
- Recurrent aphthous stomatitis
- Drug delivery
- Oral
- Chewing gum
How to Cite
References
Edgar, N.R., D. Saleh, and R.A. Miller, Recurrent aphthous stomatitis: a review. The Journal of clinical and aesthetic dermatology, 2017. 10(3): p. 26.
Akintoye, S.O. and M.S. Greenberg, Recurrent aphthous stomatitis. Dent Clin North Am, 2014. 58(2): p. 281-97.
Manoj, M.A., et al., Prevalence and risk factors of recurrent aphthous stomatitis among college students at Mangalore, India. PeerJ, 2023. 11: p. e14998.
Rivera, C., et al., Risk factors for recurrent aphthous stomatitis: a systematic review. 2021.
Sun, A., et al., Significant association of deficiencies of hemoglobin, iron, vitamin B12, and folic acid and high homocysteine level with recurrent aphthous stomatitis. Journal of Oral Pathology & Medicine, 2015. 44(4): p. 300-305.
Piskin, S., et al., Serum iron, ferritin, folic acid, and vitamin B12 levels in recurrent aphthous stomatitis. Journal of the European Academy of Dermatology and Venereology, 2002. 16(1): p. 66-67.
Kunikullaya, U., et al., Stress as a cause of recurrent aphthous stomatitis and its correlation with salivary stress markers. Chin J Physiol, 2017. 60(4): p. 226-30.
Belenguer-Guallar, I., Y. Jiménez-Soriano, and A. Claramunt-Lozano, Treatment of recurrent aphthous stomatitis. A literature review. J Clin Exp Dent, 2014. 6(2): p. e168-74.
Baccaglini, L., et al., Urban legends: recurrent aphthous stomatitis. Oral diseases, 2011. 17(8): p. 755-770.
Femiano, F., et al., Pilot study on recurrent aphthous stomatitis (RAS): a randomized placebo-controlled trial for the comparative therapeutic effects of systemic prednisone and systemic montelukast in subjects unresponsive to topical therapy. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 2010. 109(3): p. 402-407.
Liu, H., et al., Efficacy of Topical Intervention for Recurrent Aphthous Stomatitis: A Network Meta-Analysis. Medicina, 2022. 58(6): p. 771.
Shrivastava, K., et al., Comparative evaluation of the efficacy of topical amlexanox 5% oral paste and triamcinolone acetonide 0.1% oral paste in the treatment of Recurrent Aphthous Stomatitis (RAS). Journal of Indian Academy of Oral Medicine and Radiology, 2018. 30(3): p. 235-240.
Mehdipour, M., et al., A comparison of the effect of triamcinolone ointment and mouthwash with or without zinc on the healing process of aphthous stomatitis lesions. J Dent Res Dent Clin Dent Prospects, 2016. 10(2): p. 87-91.
Deshmukh, R.A. and A.S. Bagewadi, Comparison of effectiveness of curcumin with triamcinolone acetonide in the gel form in treatment of minor recurrent aphthous stomatitis: A randomized clinical trial. International journal of pharmaceutical investigation, 2014. 4(3): p. 138.
Aslani, A. and F. Rostami, Medicated chewing gum, a novel drug delivery system. J Res Med Sci, 2015. 20(4): p. 403-11.
Jain, N., et al., Medicated chewing gums - A novel targeted drug delivery. Journal of Indian Academy of Oral Medicine and Radiology, 2019. 31(1): p. 62-65.
Jacobsen, J., L.L. Christrup, and N.-H. Jensen, Medicated chewing gum: Pros and Cons. American journal of drug delivery, 2004. 2: p. 75-88.
Kaushik, P. and D. Kaushik, Medicated chewing gums: Recent patents and patented technology platforms. Recent patents on drug delivery & formulation, 2019. 13(3): p. 184-191.
Surana, A.S., Chewing gum: A friendly oral mucosal drug delivery system. Int J Pharm Sci Rev Res, 2010. 4(2): p. 68-71.
Karami-Nogourani, M., R. Kowsari-Isfahan, and M. Hosseini-Beheshti, The effect of chewing gum's flavor on salivary flow rate and pH. Dent Res J (Isfahan), 2011. 8(Suppl 1): p. S71-5.
Shah, V., et al., CHEWING GUM: A BOON FOR ORAL DRUG DELIVERY. Nirma University Journal of Pharmaceutical Sciences, 2017. 4(1): p. 3-18.
Na, D.H., et al., Chewing gum of antimicrobial decapeptide (KSL) as a sustained antiplaque agent: preformulation study. Journal of Controlled Release, 2005. 107(1): p. 122-130.
Council of, E., et al., European pharmacopoeia. 2010, Council Of Europe : European Directorate for the Quality of Medicines and Healthcare: Strasbourg.
Zhou, Y., et al., Evaluation of penicillin G potassium troches in the treatment of minor recurrent aphthous ulceration in a Chinese cohort: a randomized, double-blinded, placebo and no-treatment–controlled, multicenter clinical trial. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 2010. 109(4): p. 561-566.
Gupta, S.V., V. krushnarao Lohe, and R.R. Bhowate, Comparison of efficacy of Natural honey and Triamcinolone acetonide (0.1%) in the healing of oral ulcers ?? A clinical study. Journal Of Apitherapy, 2017. 3(1): p. 1-8.
Rahmani, F., et al., Effect of 0.5% Chitosan mouthwash on recurrent aphthous stomatitis: a randomized double-blind crossover clinical trial. Electron Physician, 2018. 10(6): p. 6912-6919.
Deshmukh, R.A. and A.S. Bagewadi, Comparison of effectiveness of curcumin with triamcinolone acetonide in the gel form in treatment of minor recurrent aphthous stomatitis: A randomized clinical trial. Int J Pharm Investig, 2014. 4(3): p. 138-41.
Plewa, M.C. and K. Chatterjee, Recurrent aphthous stomatitis. 2017.
Liu, C., et al., Efficacy and safety of dexamethasone ointment on recurrent aphthous ulceration. The American journal of medicine, 2012. 125(3): p. 292-301.
Quijano, D. and M. Rodríguez, Topical corticosteroids in recurrent aphthous stomatitis. Systematic review. Acta Otorrinolaringologica (English Edition), 2008. 59(6): p. 298-307.
Mishra, P., et al., Herbal chewing Gum to Treat Mouth Ulcer using Guava Leaf and Turmeric Rhizomes. IJCMCR. 2022; 21 (5), 2022. 1.
Augusthy, A.R., Formulation and evaluation of medicated chewing gums containing Methyl Prednisolone IP.
Mark, H.F., Encyclopedia of polymer science and technology, 15 volume set. Vol. 14. 2014: Wiley New York, NY, USA:.
Gutiérrez-López, G.F., J. Welti-Chanes, and E. Parada-Arias, Food engineering: Integrated approaches. 2008: Springer Science & Business Media.
Maggi, L., et al., Preparation and evaluation of release characteristics of 3TabGum, a novel chewing device. European Journal of Pharmaceutical Sciences, 2005. 24(5): p. 487-493.
Rassing, M.R., Chewing gum as a drug delivery system. Advanced drug delivery reviews, 1994. 13(1-2): p. 89-121.
Yadav, H.K., et al., Formulation and evaluation of medicated chewing gum as antiplaque and antibacterial agent. Journal of Young Pharmacists, 2014. 6(4): p. 3.
Christrup, L., et al., Deposition of a model substance, 99m Tc E-HIDA, in the oral cavity after administration of lozenges, chewing gum and sublingual tablets. International journal of pharmaceutics, 1990. 66(1-3): p. 169-174.
Koch, E.A., et al., Poor adherence to self-applied topical drug treatment is a common source of low lesion clearance in patients with actinic keratosis—a cross-sectional study. Journal of Clinical Medicine, 2023. 12(11): p. 3813.
Sankar, V., et al., Local drug delivery for oral mucosal diseases: challenges and opportunities. Oral diseases, 2011. 17: p. 73-84.
- Abstract Viewed: 154 times
- IJPS_Volume21_Issue1_Pages61-69 Downloaded: 75 times